2003.Evidence for an autoimmune pathogenesis of vitiligo,Pigment Cell Res 16 90 -100
LabergeG,MaillouxCM,GowanK,HollandP,BennettDC, 2005.Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo,Pigment Cell Res 18 300 -5
AlkhateebA,FainPR,ThodyA,BennettDC,SpritzRA, 2003.Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families,Pigment Cell Res 16 208 -14
EspositoM,SodaR,CostanzoA,ChimentiS., 2004.Treatment of vitiligo with the 308nm excimer laser,Clin Exp Dermatol 29 133 -7
GrimesPE, 1993.Vitiligo: An overview of therapeutic approaches,Dermatol Clin 11 325 -38
GawkrodgerDJ,OrmerodAD,ShawL,Mauri-SoleI,WhittonME, 2008.Guideline for the diagnosis and management of vitiligo,Br J Dermatol 159 1051 -76
KostovicK,NolaI,BucanZ,SitumM., 2003.Treatment of vitiligo: current methods and new approaches,Acta Dermatovenerol Croat 11 163 -70
KostovicK,PasicA, 2005.New treatment modalities for vitiligo:focus on topical immunomodulators,Drugs 65 447 -59
NordulundJJ,HalderRM,GrimesP, 1993.Management of vitiligo,Dermatol Clin 11 27 -33
GrimsPE,MorrisR,Avaniss-AghajaniE,SorianoT,MerazM, 2004.Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines,J Am Acad Dermatol 51 52 -61
KangHY,ChoiYM, 2006.FK506 increases pigmentation and migration of human melanocytes,Br J Dermatol 155 1037 -40
HuangH,WangX,DingX,XuQ,HwangSK, 2014.Effect and mechanism of tacrolimus on melanogenesis on A375 human melanoma cells,Chin Med J (Engl) 127 2966 -71
SilverbergNB,LinP,TravisI,Farley-LiJ,ManciniAJ, 2004.Tacrolimus ointment promotes repigmentation of vitiligo in children: a review of 57 cases,J Am Acad Dermatol 51 760 -6
LoYH,ChengGS,HuangCC,ChangWY,WuCS, 2010.Efficacy and safety of topical tacrolimus for the treatment of face and neck vitiligo,J Dermatol 37 125 -9
WhittonM,AshcroftD,BarrettCW,GonzalezU, 2006.Interventions for vitiligo,Cochrane Database Syst Rev 1 CD003263 -
LepeV,MoncadaB,Castanedo-CazaresJP,Torres-AlvarezMB,OrtizCA,TorresRubalcava AB, 2003.A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo,Arch Dermatol 139 581 -5
KanwarAJ,DograS,ParsadD., 2004.Topical tacrolimus for treatment of childhood vitiligo in Asians,Clin Exp Dermatol 29 589 -92
AlmeidaP,BorregoL,Rodriguez-LopezJ,LujanD,CameselleD,HernandezB, 2005.Vitiligo: treatment of 12 cases with topical tacrolimus,Actas Dermosifiliogr 96 159 -63
KumariJ, 1984.Vitiligo treated with topical clobetasol propionate,Arch Dermatol 120 631 -5
AgrawalD,ShajilEM,MarfatiaYS,BegumR., 2004.Study on the antioxidant status of vitiligo patients of different age groups in Baroda,Pigment Cell Res 17 289 -94
TsiskarishviliNV,TsiskarishviliTI, 2006.Antioxidants in vitiligo treatment,Georgian Med News 134 80 -3